The UMass Chan Diabetes Center of Excellence (DCOE) congratulates Doug Melton, PhD, who was awarded the Doctor Juan Abarca International Award for Medical Sciences for pioneering the process of converting stem cells into insulin-producing beta cells. Dr. Melton is the founder of Harvard’s Stem Cell and Regenerative Biology Laboratory. For over a decade, the UMass DCOE has collaborated with the Melton lab to further characterize these cells’ survival and function in our novel humanized mouse models. We share a common goal of protecting them from autoimmune attack.
Recent Posts
- Translational Longevity Takes Center Stage: New Report and Boston Summit Aim to Bridge the Gap Between Discovery and Patient Care
- Genetic ‘switches’ could program 3D-printed bone tissue for blood vessel growth
- AI Helps Identify Regulatory Hub for Aging in Hematopoietic Stem Cells
- First-in-human pilot trial improves stem cell collection and delivery for sickle cell gene therapy
- Scientists Supercharge Natural Killer Cells To Attack Solid Tumors
- Pluripotency, differentiation, and reprogramming: 20 years of induced pluripotent stem cells

